Healthy volunteers test new Drug's safety in Early-Stage trial
NCT ID NCT07024797
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This early-stage study tested the safety and how the body handles ABBV-932, an oral drug, in 20 healthy Chinese adults. Participants took multiple doses to see how the drug moves through the body and if it causes side effects. The goal was to gather information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Mental Health Center /ID# 273427
Shanghai, Shanghai Municipality, 200030, China
Conditions
Explore the condition pages connected to this study.